GSK plc
Search results
AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
Our company. We are a global, science-led, patient-focused pharmaceutical company. We are dedicated to transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet.
The AstraZeneca R&D facility in Gothenburg, Sweden The new AstraZeneca Corporate HQ under construction in Cambridge, England. AstraZeneca develops, manufactures and sells pharmaceutical and biotechnology products to treat disorders in the oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation areas.
At AstraZeneca we’re united by our desire to push the boundaries of science to deliver life-changing medicines. We know it’s how we will continue to transform the lives of millions of patients around the world while delivering value to our employees, our communities, and the environment.
Jul 14, 2024 · AstraZeneca, British-Swedish biopharmaceutical company with medicine sales in more than 130 countries, making it one of the largest drug companies in the world. AstraZeneca’s main research and development areas include oncology, rare diseases, and biopharmaceutical intervention, and it has numerous.
23 hours ago · Sales in AstraZeneca's top business, oncology, grew 19% at constant currency rates to $5.33 billion and accounted for 41% of the total, while its rare disease and heart and kidney disease ...
The AstraZeneca vaccine has an efficacy of 72% against symptomatic SARS-CoV-2 infection, as shown by the primary analysis of data irrespective of interdose interval from trial participants who received 2 standard doses with an interval varying from about 4 to 12 weeks.
The Oxford-AstraZeneca vaccine requires two doses, given four weeks apart, to prime the immune system to fight off the coronavirus. During the clinical trial of the vaccine, the researchers...
Sep 27, 2023 · AstraZeneca India Private Limited (AZIPL) is the global capability centre responsible for driving AstraZeneca’s digital agenda, strengthening digital infrastructure and developing technological capabilities that aids in effective and faster delivery of medicines and enhancing our patient experience. With offices in Chennai and Bengaluru, the ...
AstraZeneca India is a dedicated biopharmaceutical company discovering and developing innovative medicines for life-changing diseases. Learn more about our India chapter and our global edge, here.
